AcasăRomania & Moldova NewsINSP: 68 cases of Omicron variant of SARS-CoV-2 confirmed April 17-23

INSP: 68 cases of Omicron variant of SARS-CoV-2 confirmed April 17-23

Published on

The National Institute of Public Health (INSP) informed that, in the week April 17-23, a number of 68 cases of the Omicron variant of SARS-CoV-2 were confirmed, of which 66 are variants of interest (VOI), write Agerpres.

Of the 66 VOI cases, 2 are confirmed with the Omicron variant, sub-variant BA.2.75, 4 cases with BQ.1, 28 cases with XBB and 32 with XBB 1.5.

So far 184 cases have been confirmed with BA.2.75 sub-variant, 543 cases with BQ.1, 133 cases with XBB sub-variant and 238 with Omicron sub-variant XBB.1.5.

Up to April 23, 2023, 9,994 cases have been confirmed with the Omicron variant of concern (VOC), of which 3,073 have been detected with the BA.2 sub-variant (31pct), 62 cases have been detected with the BA.4 sub-variant (0.62pct), and 3,481 cases with the BA.5 sub-variant (35pct).

The INSP reports that 19,555 sequences have been reported to the CNSCBT by April 23.

The 68 sequences of week April 17-23 were reported by INBI Bals (48) and INCDMM Cantacuzino (20).

Latest articles

Euro trades at 4.9765 RON

The exchange rate of the national leu currency resulting from the quotations announced on...

Antibiotice Iasi reports net profit of 87.9 million RON, up 15 pct, in first nine months

Romanian drug manufacturer Antibiotice Iasi recorded a net profit of 87.9 million RON in...

Fondul Proprietatea, profit of 209.6 million RON in the first nine months

Fondul Proprietatea ended the first nine months of this year with a net profit...

Bucharest Stock Exchange opens Friday’s session in the red on most indices

The Bucharest Stock Exchange (BVB) opened with declines on most indices on Friday, and...

More like this

Euro trades at 4.9765 RON

The exchange rate of the national leu currency resulting from the quotations announced on...

Antibiotice Iasi reports net profit of 87.9 million RON, up 15 pct, in first nine months

Romanian drug manufacturer Antibiotice Iasi recorded a net profit of 87.9 million RON in...

Fondul Proprietatea, profit of 209.6 million RON in the first nine months

Fondul Proprietatea ended the first nine months of this year with a net profit...